These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8580268)

  • 1. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system.
    Reynolds PD; Middleton SJ; Shorthouse M; Hunter JO
    Aliment Pharmacol Ther; 1995 Oct; 9(5):491-5. PubMed ID: 8580268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of prostaglandin synthetase in human rectal mucosa.
    Hawkey CJ; Lo Casto M
    Gut; 1983 Mar; 24(3):213-7. PubMed ID: 6131017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM; Bartholomew TC; Jewell DP
    Gut; 1981 Aug; 22(8):642-7. PubMed ID: 6116649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kumamoto T; Matsuda A; Kataoka M; Kokuba Y
    Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
    Gibson PR; Jewell DP
    Clin Sci (Lond); 1985 Aug; 69(2):177-84. PubMed ID: 2866061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.
    Allgayer H; Eisenburg J; Paumgartner G
    Eur J Clin Pharmacol; 1984; 26(4):449-51. PubMed ID: 6428914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased suppressor cell activity in inflammatory bowel disease.
    Holdstock G; Chastenay BF; Krawitt EL
    Gut; 1981 Dec; 22(12):1025-30. PubMed ID: 6119275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine.
    Stretch GL; Campbell BJ; Dwarakanath AD; Yaqoob M; Stevenson A; Morris AI; Rhodes JM
    Aliment Pharmacol Ther; 1996 Dec; 10(6):941-7. PubMed ID: 8971292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation.
    Nielsen ST; Beninati L; Buonato CB
    Scand J Gastroenterol; 1988 Apr; 23(3):272-6. PubMed ID: 2898806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression.
    Haskó G; Szabó C; Németh ZH; Deitch EA
    Immunology; 2001 Aug; 103(4):473-8. PubMed ID: 11529938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.
    Szumlanski CL; Weinshilboum RM
    Br J Clin Pharmacol; 1995 Apr; 39(4):456-9. PubMed ID: 7640156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
    Sheldon P; Pell P
    Adv Exp Med Biol; 1995; 371B():905-8. PubMed ID: 7502923
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 5-aminosalicylic acid (5-ASA) and other salicylates on short-chain fat metabolism in the colonic mucosa. Pharmacological implications for ulcerative colitis.
    Roediger W; Schapel G; Lawson M; Radcliffe B; Nance S
    Biochem Pharmacol; 1986 Jan; 35(2):221-5. PubMed ID: 2867767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
    Kles KA; Vavricka SR; Turner JR; Musch MW; Hanauer SB; Chang EB
    Inflamm Bowel Dis; 2005 Mar; 11(3):253-7. PubMed ID: 15735431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
    Kimura I; Kawasaki M; Nagahama S; Matsuda A; Kataoka M; Kokuba Y
    Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
    Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions.
    Grisham MB; Miles AM
    Biochem Pharmacol; 1994 May; 47(10):1897-902. PubMed ID: 8204107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation.
    Rachmilewitz D; Karmeli F; Schwartz LW; Simon PL
    Gut; 1992 Jul; 33(7):929-32. PubMed ID: 1353743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.